Developing Pharmaceutical Supply Chain Resilient Capabilities: The Role of Industry 4.0 Technologies

Abstract

Purpose: Building resilience in pharmaceutical supply chains (PSCs) has become imperative in the wake of COVID-19 and other global disruptions. This study advances understanding of how PSCs can be re-imagined, re-designed, and strengthened by leveraging Industry 4.0 (I4.0) technologies. Design/methodology/approach: We adopted a qualitative approach using thematic analysis and the Gioia method on a corpus of data from 114 articles published in 84 peer-reviewed academic journals. We conducted a problematising review to critically analyse the contributions of I4.0 technologies to PSCs and demonstrate the distinctiveness of PSC resilience. Findings: The thematic analysis revealed the advantages and barriers to I4.0 implementation in PSCs, emphasising on how these technologies support sensing, seizing, and reconfiguring capabilities. Drawing on Dynamic Capability Theory (DCT), we propose the Pharmaceutical Supply Chain Resilient Capabilities (PSCRC) model, which conceptualises the capability building required to withstand and adapt to disruption. Originality/Value: We argue that the PSCRC model provides i) a theoretical contribution by clarifying the micro foundations of resilience, and ii) a practical roadmap for supply chain leaders seeking to deploy I4.0 technologies to coordinate processes, secure materials, and build sustainable and adaptive PSCs. The paper also outlines future research avenues to advance scholarly and managerial understanding of PSC resilience.